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ABSTRACT  The postulated role of the acetylcholine receptor in the formation of neuromuscular 
synapses during the course of embryonic development was investigated in the superior oblique 
muscle of white Peking duck embryos. The possibility that the number of receptors could be 
experimentally  lowered  by  chronic  injections  of  the  anticholinesterase agent,  neostigmine 
methylsulfate, was determined  using 1251-~-bungarotoxin. The total  number of acetylcholine 
receptors on incubation day 12, 2 d subsequent to the onset of treatment, was reducted 45% 
as compared to saline-treated controls. A similar reduction in total receptor content (49%) was 
also observed on day 19. Radioautographic preparations showed that clusters of acetylcholine 
receptors were rare and that the grain density of extrajunctional receptors was also reduced. 
Hence,  chronic treatment with  neostigimine during development was observed to  exert an 
effect on  both the number and distribution of  receptors in the developing superior oblique 
muscle. These changes occurred in the absence of any apparent effect on muscle differentiation 
in general. Myoblasts and  myotubes were  present on day 14 and  further differentiated  into 
myofibers  by  day  18  in  both  neostigmine and  saline-treated  muscles. The  cytology of  the 
developing  muscle  cells  also  appeared  normal.  This  is  in  contradistinction to  the  striking 
morphological changes that take place in adult mammalian and avian muscle after anticholin- 
esterase  treatment.  More significantly, the decreased  total  receptor content and  sparsity of 
clusters had no apparent effect on the formation of developing neuromuscular junctions at the 
electron microscopic level. The frequency of neuromuscular junctions in neostigmine-treated 
muscles was similar to that of the controls. It is concluded that acetylcholine receptor clusters 
are  not  required  for  the  events  leading to  the  morphological  formation  of  neuromuscular 
junctions during in vivo development. 
Although initially developing independently, a skeletal muscle 
and its  motor nerve become structurally and functionally de- 
pendent on each other during subsequent embryonic develop- 
ment through a complex series of interactions eventually lead- 
ing to the formation of neuromuscular junctions (NMJs). The 
mechanisms by which NMJs are established, either during the 
course  of embryonic development  or  after  reinnervation  of 
adult  denervated  muscle,  are  little  understood.  One  of the 
extensively investigated aspects of the NMJ is the presence of 
acetylcholine receptor (AchR) molecules in the plasma mem- 
brane of the muscle fiber. In relatively immature muscle cells 
the  AchRs  are  distributed  uniformly over  the  entire  sarco- 
lemma (7,  17). An integral part of the maturation  process of 
the developing muscle is the change in distribution and number 
of AChRs,  and  in  many  properties  of the  receptor  such  as 
metabolic turnover times, channel open times, and immuno- 
logical properties (9,  10,  19, 22, 48, 51, 67). At about the time 
of the initial innervation, aggregates of AchRs (clusters or hot 
spots) appear in addition to the relatively low density receptors 
(7, 8). Although temporally coincidental, the initial appearance 
of clusters of receptors is not dependent on innervation because 
the receptor clusters appear on myotubes grown in culture in 
the absence of neural tissue and in aneural muscle (3, 4, 8, 2 l, 
55, 63).  In vitro studies suggest that the growing nerve fibers 
induce  new  receptor  clusters  at  the  point  of nerve-muscle 
contact  (3,  24).  Gradually,  during  the  course  of embryonic 
development, the low density receptors disappear and almost 
all AchRs in the adult muscle fiber are localized to the region 
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pertaining to synaptogenesis is what role, if any, do the AchR 
clusters play in formation of the NMJ? 
In this paper we report the effects of neostigmine methylsul- 
fate on the embryonic development of AchRs,  formation and 
maintenance of NMJs, and muscle differentiation. Neostigmine 
methylsulfate  and  other  anticholinesterase  drugs  have  been 
shown  to  produce  postsynaptic  morphological,  biochemical, 
and electrophysiological alterations in adult mammalian skel- 
etal muscle after acute and long-term treatment (1,  18, 20, 23, 
30, 34, 37, 38, 49, 52, 64, 66). Initially, the myopathic changes 
are localized to the junctional region and include disruption of 
the  myofibrillar  apparatus,  swelling  of subjunctional  mem- 
brane-bound  organeUes,  and  a  simplification of postsynaptic 
folds (18,  30,  34,  52). With continued  treatment, the degener- 
ative changes spread to regions adjacent to the motor endplate. 
Furthermore,  chronic treatment  of adult  mammalian muscle 
with  neostigmine  reduces  the  total  number  of acetylcholine 
receptors in the range of 42-45% in the endplate  region (12, 
44). Whether or not neostigmine also decreases the total num- 
ber  of AchRs  in  the  embryonic  skeletal  muscle  and  alters 
muscle morphology during in vivo development is unknown. 
MATERIALS  AND  METHODS 
Animals and Drug Regimen 
White Peking duck embryos were treated with 1-5/tg neostigmine methylsui- 
fate (prostigmin, Roche Laboratories, Hoffman-LaRoche, Inc., Nutley, N J) per 
gram body weight. The drug solution was placed on the vascularized chorioal- 
lantoic membrane through an opening in the shell beginning on day  10 and 
continuing daily until sacrifice. Previous studies have shown that the out-growing 
trochlear nerve fibers reach their target, the superior oblique muscle, on day 10; 
neuromuscular transmission begins on  day  11,  and  primitive  neuromuscular 
junctions first become visible on day 13 (56, 58, 59, 62). Control embryos received 
equal amounts of a  sterile,  physiological saline  solution  over the  same time 
period. 
Acetylcholine  Receptor Binding 
and A utoradiography 
Acetylcholine receptor quantification was performed by conjugating Na12~I 
(Amersham Corp., Arlington Heights, IL) with a-bungarotoxin (a-BTX, Miami 
Serpantarium, Miami, FL) using the chloramine-T method (5, 28). Upon sacrifice 
muscles were quickly dissected and each muscle was incubated at 4°C for 4 h in 
1 ml Locke's solution containing 0.3/~g v2sI a-BTX (sp act 57 Ci/mM). Subse- 
quently, the muscles were washed overnight in Locke's solution at 4°C to remove 
unbound toxin. The amount of bound a2sI a-BTX (hence receptor content) was 
determined with a gamma counter. The nonspecific binding in our preparations, 
as determined by preincubation of muscles with cold toxin, was 7%. Total muscle 
protein was determined from muscle homogenates by the method of Lowry et al. 
(40) using bovine serum albumin as the standard. 
For autoradiography the superior oblique muscles were labeled and washed 
as described above with the one exception that an iodinated toxin of higher 
specific activity was used (200 Ci/mM, Amersham Corp.). Subsequent to wash- 
ing,  the  muscles were fixed  for 4  h  in  4%  paraformaldehyde-glutaraldehyde 
solution. They were then washed in  Locke's solution for 6  h  (4°C), frozen in 
liquid nitrogen, and longitudinally sectioned on a  cryostat at 20/tm.  Sections 
were coated with NTB-2 liquid emulsion (Kodak) diluted 1:1 with water. After 
a 6-d exposure at 4°C, the slides were hydrated, developed for 3 rain at 18-20°C 
(2 parts H20 to 1 part DI9), and fixed. The slides were then hghtly stained with 
hematoxylin and eosin and cover-slipped. Muscles on embryonic days 11, 16, 19, 
and 23 were processed for autoradiography. Quantitative autoradiographic stud- 
ies were performed on embryonic day 23. AchR clusters were counted with the 
aid of a camera lucida drawing tube attached to a light microscope. Silver grain 
counts of extrajunctional AchRs were made from photographs at a final magni- 
fication of 850 times. The areas were measured with a Zeiss MOP-1. 
Light and Electron Microscopy 
For electron microscopy, muscles were fixed overnight in 4% paraformalde- 
hyde-glutaraldehyde, pH 7.4, postf2xed in  1% osmium tetroxide, stained en bloc 
with  0.5%  aqueous uranyl acetate,  dehydrated through graded ethanols  and 
embedded in Epon  812. Thin sections of 500-1,000 A  were cut on  a  Sorvall 
MT2B ultramicrotome (DuPont Instruments, Newtown, CT). Sections were taken 
at  250-/tin increments of the  muscle in  both longitudinal and cross-sectional 
orientations. The sections were stained with lead citrate and viewed on a Philips 
400 transmission electron microscope. For quantitative electron microscopy on 
NMJs, muscles on embryonic day 23 were cut lengthwise into two parts and both 
parts were embedded to atlow visualization of the entire width of muscle in cross 
section. Thin sections were obtained from three different areas of the muscle at 
increments of 1.5 ram. A  neuromuscular junction was defined as the region of 
contact between a  nerve terminal and muscle cell and showed the  following 
characteristics: local thickening of the postsynaptic membrane, a distinct synaptic 
cleft, and a presynaptic nerve terminal containing synaptic vesicles. 
The uptake of neostigmine into the circulation and its action on the muscle 
were monitored by staining muscles for acetylcholinesterase. Muscles were dis- 
sected, frozen in liquid nitrogen, sectioned at 40 ttm and processed for demon- 
stration of acetylcholinesterase according  to the method of Toop (65). In addition, 
embryonic motility was monitored by counting vigorous, jerky limb movements 
through the shell window for an interval of 5 min on embryonic days 12, 14, 16, 
and 18. 
RESULTS 
Effects of Neostigmine on 
Acetylcholine  Receptors 
A total of 148 duck embryos was injected daily with neostig- 
mine methylsulfate (3.0 #g neostigmine/g body wt) beginning 
on day 10 and continuing until sacrifice. At this concentration, 
the  drug  elicited  a  maximum  response  while  not  increasing 
embryonic mortality above normal levels. 
Continuous neostigmine application reduced the number of 
acetylcholine receptors in the superior oblique muscle as also 
observed by others in adult mammalian muscle (12, 44). Total 
counts per minute on day  12, 2 d  subsequent  to the onset of 
neostigmine  treatment,  were  decreased  45%  as  compared  to 
saline-treated controls (Fig.  1). This relation remained essen- 
tially unchanged through day 19 when a 49% reduction in the 
receptor content was observed. However, values for total mus- 
cle protein in neostigmine-treated muscles were comparable to 
control muscles on both days (Fig.  1). Hence, the decrease in 
receptor  number  in  neostigmine-treated  embryos  cannot  be 
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FIGURE  1  Total  1125~-bungar - 
otoxin  binding  per  muscle 
(bottom)  and  total  muscle 
protein  in  the  control  and 
neo-stigmine-treated  superior 
oblique  muscle.  Data  are  ex- 
pressed  as  mean  +  SEM.  N  = 
9-12 muscles. 
SOHAL  AND  BOYDsTON  541 normal muscles were preincubated with neostigmine for  1 h, 
no  significant  differences  in  the  total  number  of  receptors 
between  the  treated  and  nontreated  muscles  were  observed 
suggesting that neostigmine does not inhibit a-BTX binding to 
the  receptor.  Injections of neostigmine during  the  course  of 
embryonic development therefore appeared to have an identi- 
cal effect  on  the  total  number  of acetylcholine receptors as 
reported in adult muscle (12, 44). 
In contrast to adult innervated muscle, embryonic muscle is 
characterized by populations of both junctional and extraj  u nc- 
tional receptors. Thus,  the question arises as to how the neo- 
stigmine-induced  reduction  in  receptor  number  is  affecting 
receptor  distribution.  Fig.  2a  shows  the  typical  pattern  of 
receptor distribution on  day 23  in  saline-treated controls.  In 
FIGURE  2  Autoradiographic  demonstration  of acetylcholine  receptor distribution  in  superior oblique  muscle  on  embryonic  day 
23.  a, control;  b, neostigmine-treated.  Note the sparsity of both clusters of receptors as well as extrajunctional  receptors in  b. x  525. 
542  THe  JOURNAL OF  CELL BIOLOGY • VOLUME 94, 1982 addition  to  the  extrajunctional  receptors,  obvious  receptor 
clusters  were  seen.  However,  such  clusters  were  sparse  in 
neostigmine-treated  muscles (Fig.  2 b).  Quantitative  study of 
receptor  clusters  indicated  that  -85%  of the  clusters  were 
absent  in the  neostigmine-treated  embryos  (Table  I).  When 
present,  the area of the remaining clusters was considerably 
smaller (Table  II). Counts of silver grains indicated that the 
extrajunctional receptors were also fewer in number in neostig- 
mine-treated embryos (Table II). Thus, reduction in total num- 
ber of receptors after neostigmine treatment is due to loss of 
both clusters of receptors and extrajunctional receptors. 
Effects of Neostigmine on Neuromuscular 
Junction Formation and Muscle Differentiation 
To verify the anticholinesterase nature of neostigmine in a 
developing muscle  system,  an  acetylcholinesterase  stain  was 
performed. By staining cholinesterase deposits at the junctional 
regions, this procedure allows for the demonstration' of motor 
endplates  at  the light  microscopic level.  In Fig.  3 a,  distinct 
acetylcholinesterase deposits are seen in the control muscle on 
day 23.  This staining was absent when tissues were preincu- 
bated with neostigmine for 30 min. Normally, the first appear- 
ance  of endplates  detectable  in  the superior  oblique  muscle 
with this stain is on incubation day 18. On the other hand, an 
absence of distinct acetylcholinesterase staining of motor end- 
plates  was  noticed  in  neostigmine-treated  embryos  despite 
TABLE  I 
Number of  Acetylcholine Receptor Clusters and Neuromuscular 
Junctions in Control and Neostigmine-treated Superior Oblique 
Muscles on Embryonic Day 23 
Series  AchR Clusters  NMIs 
Controls 
C-3  84.33  32.66 
C-4  100,93  44.33 
C-5  64.15  41.0 
Neostigmine-treated 
NST-42  13.16  38.66 
N ST-43  15.82  33.66 
NST-44  9.62  38.09 
Mean +  SEM 
Control  83.13 4- 10.63  39.33 4- 3.47 
Neostigmine-treated  12,86 +_ 1.79"  36.80 ±  1.58 
Data are expressed  as number of AchR clusters  and  NMIs per section.  In 
each case one muscle  was processed for I  ~25 ~x-BTX autoradiography and the 
opposite  muscle  of the same  embryo was  used  for electron  microscopy. 
Counts of AchR clusters  were made from  every third  section.  NMJs were 
counted from thin transverse sections at X 10,000 from three different levels 
of the muscle  (at increments of 1.5 mm). 
*  P< 0.001 {Student's  t test). 
TABLE  II 
Acetylcholine Receptor Cluster Area and Extra  junctional Recep- 
tor Silver-Grain  Density in  the Superior  Oblique Muscle on 
Embryonic  Day 23 
Silver grains/100 
Group  AchR cluster area  ~m 2 
#m  2 
Control  144.58 +_ 9.01  (79)  20.96 +  1.25  (25) 
Neostigmine-treated  90.21  4- 5.69*  (94)  12.09 +  0.57*  (47) 
Data are expressed as Mean :1: SEM. The number of clusters  measured  and 
the  number of different sites  for extrajunctional  grain density counts  are 
given  in  parentheses.  The  autoradiographic  pictures  used  for  the  above 
measurements  were those  used for the study in Table  I. 
*  P< 0.001 {Student's  t test). 
repeated tissue washing of up to 2 h  (Fig. 3 b (possible expla- 
nations  for  lack  of cholinesterase  staining  in  neostigmine- 
treated muscles and difficulties with this experiment are con- 
sidered  in  the  last  paragraph  of discussion).  Upon  electron 
microscopic examination of treated muscles on days 14, 16, 19, 
and 23, neuromuscular junctions appeared normal morpholog- 
ically  and  their  temporal  appearance  coincided  with  those 
observed in saline-treated control muscle (Fig. 4 a). Hence, no 
differences in the time of appearance or structure of developing 
neuromuscular junctions occurred. In view of the loss of a vast 
majority of clusters it was of considerable interest to determine 
whether  or  not  the  number  of neuromuscular junctions  in 
neostigmine-treated  embryos was  comparable  to that  of the 
control. An ideal approach would be to count the number of 
motor endplates from muscles stained with a combined acetyl- 
cholinesterase  and  silver  impregnation  method  at  the  light 
microscope level.  Unfortunately, lack of acetylcholinesterase 
staining in neostigmine-treated muscles precluded this type of 
analysis. However, some indication of the frequency of neu- 
romuscular junctions was obtained using quantitative electron 
microscopy. Table  I  indicates  that  the  frequency of finding 
neuromuscular junctions in the treated embryos was similar to 
that of the controls. 
A  cursory look at the neostigmine-treated  embryos at  the 
time of injections gave the impression of normal quantitative 
motility. However, totally different results were obtained when 
the  number  of limb  movements were  quantitated  in  a  sys- 
tematic fashion. Table III indicates that embryonic movements 
were  significantly reduced  in  the  treated  embryos.  Further- 
more,  this  reduced  level  of activity  remained  virtually  un- 
changed in the neostigmine-treated  embryos whereas  a  pro- 
gressive increase in the number of limb movements occurred 
in the control embryos. 
As striking  changes in the organization of contractile ele- 
ments and degeneration of postsynaptic folds occur in adult 
muscle after long-term anticholinesterase treatment, the effect 
of neostigmine on muscle differentiation  was examined.  The 
normal stages in the development of the superior oblique have 
been well documented and were not seen  to vary in neostig- 
mine-treated  embryos  (59).  Myoblasts  and  myotubes  were 
present on day 14 and further differentiated into myofibers by 
day 18. The cytology of the developing muscle fibers was also 
normal in the sense that the appropriate complement of organ- 
elles  was seen and myofilaments became well organized and 
assembled into myofibrils (Fig. 4 b). Numerous intramuscular 
nerve bundles of normal ultrastructure were encountered. 
Our failure to observe massive morphological alterations in 
neostigmine-treated  embryonic muscles suggested that either 
the embryonic muscle is not as susceptible to anticholinesterase 
myopathy as  the  adult  muscle  or that  for some  reason  the 
anticholinesterase myopathy does not occur in avian muscles. 
Since all of the reported anticholinesterase  myopathy studies 
were done on mammals we examined the effects of neostigmine 
treatment on the adult duck muscle. Adult ducks were given 
intraperitoneal  injections (0.05  mg/kg body weight in 0.1  ml 
solution  of neostigmine  methylsulfate)  twice  daily  for 7  d. 
Shivering and salivation was observed shortly after the injec- 
tions. Ducks injected with 0.25 mg/kg body weight of neostig- 
mine of 0.5 ml solution died within  10 min of injection. After 
sacrifice, superior oblique muscles were examined with electron 
microscopy. Myopathic changes similar to those reported for 
the  adult  mammalian  muscle  were  observed  and  a  limited 
evidence of this is provided in Fig. 5. 
SOHAL AND  BOYDSTON  Neostigmine  Treatment  and Embryonic  Development  543 FIGURE  3  Acetylcholinesterase staining of  superior oblique muscle on embryonic day 23.  a, control;  b,  neostigmine-treated. 
Distinct cholinesterase deposits are absent in the neostigmine-treated muscle,  x  200. 
DISCUSSION 
The results of the present study indicate that continued treat- 
ment of the embryo with neostigmine before, during, and after 
the  period of synaptogenesis in  the  superior oblique muscle 
significantly reduces the total number of AchRs. Despite such 
a  reduction in AchRs and the absence of clusters of receptors, 
neuromuscular junctions  of normal  ultrastructure  were  ob- 
served. Further, the progressive differentiation of the myogenic 
cells to the myofiber stage was unaffected as a  result of neo- 
stigmine treatment. These findings suggest that the total recep- 
tor content and the ability of receptors to cluster may not be 
essential elements either for the formation and maintenance of 
the  morphological aspects of the neuromuscular junctions or 
for  the  growth  and  maturation  of the  muscle.  Whether  the 
neuromuscular  junctions  were  functionally  normal  in  the 
treated  embryos  could  not  be  ascertained  with  the  present 
approach. This could only be determined by electrophysiolog- 
ical recordings. Reduced levels of embryonic motility can be 
interpreted  to  mean  fewer  physiologically normal junctions. 
544  THE  JOURNAL  OF  CELL BIOLOGY • VOLUME  94, 1982 FIGURE  4  a,  neuromuscular junction in the neostigmine-treated superior oblique muscle on embryonic day 23. ×15,3000.  b,  low 
magnification cross-sectional view of neostigmine-treated superior oblique muscle on embryonic day 23. x  5,775. 
However, the drastic reduction in the total number of receptors 
and  the  fact  that  most junctions  are  without  AchR  clusters 
could also account for reduction in activity. 
Our observations are consistent with findings in other sys- 
tems  regarding  the  role  of AchRs  in  synapse  formation.  A 
study by Anderson et al. (3, 4) has suggested that the clusters 
of receptors may be formed along the course of neurite-muscle 
contacts in  cultured Xenopus myotubes.  A  detailed mapping 
study of AchR clusters on chick myotubes grown in culture 
was  recently  carried  out  by  Frank  &  Fischbach  (24).  By 
mapping AchR  clusters before and  after synapse formation, 
they observed that  the  ingrowing nerve  fibers induced  new 
clusters of receptors rather  than  seeking out  the  preexisting 
ones. The uninnervated AchR clusters gradually disappeared 
SOHAL AND  BOYDSTON  Neostigmine  Treatment and Embryonic Development  545 FtGURE  5  a,  neuromuscular junction  in superior oblique muscle of control adult duck.  x  18,480.  b,  superior oblique muscle of 
neostigmine-treated adult duck.  Note dissolution  of Z-discs  (arrow), large mitochondria and general disorganization of muscle. 
Damaged mitochondria were observed in the presynaptic nerve terminal but not in intramuscular nerve fibers. Indistinct pre- and 
postsynaptic  membranes and displacement of  nerve terminals were frequently observed. Considerable damage to subsynaptic 
organelles although not present in this picture also occurred, x  8,250. 
suggesting that that the initial AchR clusters may not represent 
preferred sites for synapse formation. It is now clear that the 
growing neurities induce clusters of receptors at the region of 
transmitter release. The mechanism by which neurites induce 
this clustering is as yet unknown.  Several reports indicate that 
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a  factor of neural origin may be responsible for clustering of 
receptors (13,  15, 33, 47). Extracts of spinal cord or brain have 
been shown to contain a factor that increases the total number 
of AchRs and the number of receptor clusters on muscle cells 
grown in culture (33, 47). Media conditioned by neuroblastoma TABLE  III 




Movements  per minute 
Embryonic days 
72  14  16  18 
12.2 ±  0.8  23.3 --+ 0.7  28.8 _+ 1.7  38.5 ±  1.5 
3.9 --+ 0.3*  3.7 ±  0.6*  4.2 +  0.4*  5.9 +  0.7* 
Data are expressed  as mean +- SEM.  n  =  5. 
*  P<  0.001  (Student's  t  test). 
x  glioma hybird cells can also increase the total number  of 
AchR  clusters  on  myotubes  in  culture  (13).  The  molecular 
mechanism underlying the action of these factors is completely 
unknown. 
When embryonic muscle cells are cultured with neurons in 
the  presence  of  curare,  synapses  are  formed  (14,  45,  50). 
Similarly, when  neuromuscular transmission is blocked with 
pre- or postsynaptic blocking agents (such as botulinum toxin, 
hemicholinum, and bungarotoxin), neuromuscular junctions of 
normal ultrastructure develop in vivo (25, 26,  56,  59,  60).  In 
vitro studies by Steinbach et al. (61) on the clonal lines of nerve 
and  muscle cells indicate that  neither the presence of active 
AchRs nor the release of acetylcholine are a  prerequisite for 
synapse formation. Kidokoro and Yeh (35) observed that when 
Xenopus  neurons  are cultured with rat myotubes,  functional 
synapses  are  established in  the  absence  of accumulation  of 
AchR molecules at the region of nerve-muscle contact. Rein- 
nervation of the adult skeletal muscle occurs when AchRs are 
blocked with ct-bungarotoxin (31). Considering the above ob- 
servations together with the findings of the present study, it 
appears  that  none  of the  known  aspects  of the  cholinergic 
transmission are essential for the formation of NMJs. It is quite 
conceivable that something else associated with the region of 
the  nerve-muscle  contact  (perhaps  some  component  of the 
basal lamina) along with a factor of neural origin may play an 
instructive role in synapse formation (6,  1  l, 32, 41, 54). Regen- 
erating axons have been shown to innervate the intact basement 
membrane  at the original site of the NMJ  in otherwise dis- 
rupted  and  phagocytized muscle  fibers (ll, 41,  54).  Recent 
studies have  indicated that  the  basal lamina at  the  NMJ  is 
immunologically  different from that of the extrasynaptic region 
of the muscle fibers (53). 
The mechanism by which neostigmine produces biochemical 
and morphological alterations at the vertebrate NMJ has not 
yet been established. Such changes have been attributed to an 
excess amount of acetylcholine in the synaptic cleft resulting 
from  acetylcholinesterase inactivation (12,  34,  49,  66).  Since 
myopathic changes require an intact nerve supply and can be 
prevented by inactivating AchRs, it has been suggested that 
necrosis may be mediated by an  influx of Ca ++ (l,  52).  An 
alternate hypothesis involving Na  + flux has also been proposed 
(37).  Recent evidence by Leonard &  Salpeter (38)  indicates 
that low external Ca ++ prevents myopathic changes and on the 
contrary low Na  ÷ concentration has little effect. In the present 
study myopathy was absent in the embryonic muscle whereas 
necrosis  similar  to  that  observed  in  the  adult  mammalian 
muscle  occurred  in  the  adult duck.  It will be  interesting to 
examine the  relative involvement of Ca +÷  in  embryonic vs. 
adult muscle after esterase inactivation. Presently, only hypo- 
thetical mechanisms can be proposed by which neostigmine 
prevents clustering of AchRs during embryogenesis. Neostig- 
mine may prevent the release or activation of chemical factors 
from neurons which are responsible for clustering of AchRs, or 
it may interfere in the mobilization or insertion of receptors in 
the plasma membrane. It is also possible that neostigmine may 
alter the synthesis and/or degradation rate of AchRs. 
Finally, a  comment  should  be  made  with  respect  to  our 
failure to observe positive cholinesterase staining of endplates 
in neostigmine-treated embryos. Since the appearance of cho- 
linesterase at the embryonic neuromuscular junctions in vitro 
(36,  50) and after reinnervation of adult muscle in vivo (39) 
has been shown to be dependent on muscle activity and since 
activity in our embryos was drastically  reduced, it would appear 
that  cholinesterase  may  be  absent  in  our  treated  muscles. 
However,  when  embryonic  neuromuscular  transmission  is 
blocked in vivo, motor endplates stain normally  with cholin- 
esterase  stain  (16,  27,  46,  57).  Furthermore,  cholinesterase 
staining has  also  been  observed on  amphibian muscle cells 
cultured in the absence of neural tissue (43, 68). A more likely 
explanation for lack of cholinesterase staining in the present 
study may be that staining was blocked by neostigmine. This 
is supported by the fact  that  when  normal muscle was pre- 
treated with neostigmine for 30  rain and subsequently thor- 
oughly washed, cholinesterase staining was blocked. Further- 
more, despite up to 2 h of extensive washing of muscles from 
embryos chronically treated with neostigmine, no staining oc- 
curred. Thus, our observations suggest that lack of staining in 
treated embryos may be due  to a  direct inhibitory effect of 
neostigmine rather than a repressive effect. 
We are grateful to Beth McBride, Greg Oblak, and Tenna Knox for 
their excellent technical assistance and to Rosemary Widener for her 
careful typing of the manuscript. 
This work was  supported by grants  from  National Institutes  of 
Health and Muscular Dystrophy Assocation. 
Received for publication 17 August  1981, and in revised form 10 May 
1982. 
REFERENCES 
I.  Ariens, A. TH., E. Mceter, O. L. Wolthius, and R. M. J. van Bentbem.  1969. Reversible 
necrosis at the end-plate region in striated muscles of the rat poisoned with cholinestera~¢ 
inhibitors. Experiemia  (BaseO. 25:57-59. 
2.  Axelsson, J., and S. Thesleff. 1959. A study of snpersettsitivity in denervated  mammalian 
skeletal muscle. £  PhysioL  ( Lond. ), 147:178-193. 
3.  Anderson, M. J., and M. W. Cohen.  1977. Nerve-induced and spontaneous redistribution 
of acetylcholine receptors on cultured muscle cells. J. PhysioL  (Lond.).  268:757-773. 
4.  Anderson,  M. J.,  M. W.  Cohen,  and E. Zorychta.  1977. Effects of imaervation on the 
distribution  of acetylcholine  receptors  on  cultured  muscle  ceils,  d.  PhysioL  (Load.). 
268:731-756. 
5.  Berg, D. K., R. B. Kelly, P. B. Sargent, P. Wiltiamson, and Z. W. Hall.  1972. Binding of 
a-btmgarotoxin to acetylcholine receptors in mammalian muscle. Proc. NatL Acad. Sci.  U. 
S..4.69:147-15l. 
6.  Betz, W., and B. Sakmann.  1973, Effects of proteolytic enzymes on function and structure 
of frog neuromuscular junctions. J. Physiot  (Load.).  230:673-688. 
7.  Bevan, S., and J. H. Steinbach.  1977. The distribution ofa-bungarotoxin binding sites on 
mammalian skeletal muscle developing in vivo. J, Physiol.  ( Lond. ). 267:195-213. 
8.  Braithwaite, A. W., and A. J.  Hams.  1979. Neural  influence on acetylcholine  receptor 
clusters during embryonic development of skeletal muscles. Nature (Lond.). 279:549-551. 
9.  Burden, S.  1977. Development  of the neuromuscular junction in the clfick embryo: the 
number, distribution, and stability of acetylcholine receptors. Dev.  Biol.  57:317-329. 
10.  Burden, S.  1977. Acetylcholine receptors at the neuromuscular  junction:  developmental 
change in receptor turnover. Dev.  Biol.  61:79-85. 
I 1,  Burden,  S.  J.,  P.  B.  Sargent,  and  U.  J.  McMahan.  1979. Acetylcholine  receptors  in 
SOHAL  AND  BOYDSTON  Neostigmine Treatment and Embryonic Development  547 regenerating muscle accumulate at original synaptic sites in the absence  of the nerve. £ 
('ell BioL  82:412~25. 
12.  Chang,  C.  C.,  T.  F.  Chen,  and  S.  T,  Chuang.  1973.  Influence  of chronic  neostigmine 
treatment on the number of acetylcholine receptors and the release of acetylcholine from 
the rat diaphragm. J. Pt~vsioL (Lond.). 230:613-618. 
13.  Christian. C.  N.,  M.  P.  Daniels+  H. Sugiyama+ Z. Vogel, L. Jacques,  and  P.  G. Nelson. 
1978. A factor from neurons that increases the number ofacetylcholine receptor aggregates 
on cultured muscle cells. Proc.  Natl. ,4cad.  Svt  U. S. ,4. 75:40114015. 
14.  Cohen.  M. W.  1972. The development of neuromuscular connexions in the presence of d- 
tubocurarine.  Brain  Res. 41:457~163. 
15.  Cohen,  S. A.+ and G. D. Fischbach.  1977. Relative peaks of ACh sensitivity at identified 
nerve-muscle synapses in spinal cordmuscle cocultures.  Dev,  Biol.  59:24-38. 
16.  Creazzo. T. L., and G. S  SohaL  1981. Beta-bungarotoxin  lacking phospholipase  activity 
is not toxic to developing motor neurons and skeletal muscle, Dev.  Neurosci.  4:329-336. 
17.  Diamond.  J., and  R.  Miledi.  1962.  A  study  of foetal and  new-born  rat muscle fibers. J. 
PhvdoL (Lond.).  162:393~108. 
18.  Engel, A. G.. E. H. Lambert, and T. Santa.  1973.  Study  of long-term anticholinesterase 
therapy. Neurology. 23:1273  128l. 
19.  Fambrough.  D.  M.  1979.  Control  of acetylchotine  receptors  in skeletal muscle.  Pt~vsioL 
Rev, 59:165 227. 
20.  Fenicbel. G  M, W. B. Kibier. W. H. Olson, and W. D. Dettbarn.  1972. Chronic inhibition 
ofcholinesterase as a cause of myopathy.  NeuroL  22:1026  1033. 
21.  Fischbach, G. D,, and S. A. Cohen.  1973. The distribution of acetylcholine sensitivity over 
uninnervated and innervated muscle fibers grown in cell culture. Dev.  BioL  31:147+ 162. 
22.  Fischbach, G. D,. and S. M. Schuetze.  1980. A postnatal decrease in acetylcholine channel 
open time at rat endplates..L  PhvsioL  (Lond.). 303:125-138. 
23.  Fischer, G.  1970. Die Azetylcholinesterase an der motorischen endplatte des rattenzwerch- 
fells nach intoxikation mit paraoxon und soman bei apptikation yon oximen. Experimentia 
(Basel).  26:402403. 
24.  Frank. E.. and G. D. Fischbach.  1979. Early events in neuromuscular junction  formation 
in vitro..L  Cell B+oL 83:143  158, 
25.  Freeman,  S.  S.,  A,  G.  EngeL  and  D.  B.  Drachman.  1976.  Experimental  acetylcholine 
blockade of the neuromuscular junction.  Effects on endplate and muscle fiber ultrastruc- 
lure. Ann.  N.  Y. Acad.  ScL 274:46-59. 
26.  Giacobini-Robecchi.  M.  G,  G.  Giacobini.  G.  Gilogamo.  and  J.  P.  Ghangeux.  1975. 
Effects of the type  A  toxin  from  Clostridium  botulinum  on  the development  of skeletal 
muscles and of their innervation in chick embryo.  Brain  Res. 83:107+121. 
27.  Gordon.  T.. R.  Perry, A. R. Tuffery, and G. Vrbova.  1974.  Possible mechanisms  deter- 
mining  synapse  formation  in  developing  skeletal muscles  of the  chick.  Cell  Tiss.  Res. 
155:13 25. 
28.  Greenwood.  F. C., W. M. Hunter and J. S. Glover.  1963. The preparation of ~  Ul-labeled 
human  growth hormone of high specific radioactivity. Biochem. J. 89:114-123. 
29.  Hartzell.  H,  C..  and  D.  Fambrough.  1972.  Acetylcholine  receptors:  distribution  and 
extrajunctional density in rat diaphragm  after denervation  correlated  with acetylcholine 
sensitivity. J. Gen  PhvsioL  60:248-262. 
30.  Hudson.  C.  S.+ J+  E.,  Rash,  T.  N.  Tiedt. and  E.  X.  Albuquerque.  1978.  Neostigmine- 
induced  alterations  at  the  mammalian  neuromuscular  junction.  11  Uhrastructure  J. 
Pharmacol.  Exp.  Ther.  205:340-356. 
31.  Jan~n.  J.  K. S,. and  D. C, van Es~n,  1975.  Reinnervation of rat skeletal muscle in the 
presence of a-bungarotoxin..L  Ph~.sioL (Lond+)+ 250:651-667. 
32.  Jacob.  M., and  T.  L. Lentz,  1979.  Localization of acetylcholine  receptors  b 3,  means  of 
horseradish  peroxidase-~-bungarotoxin  during formation and development  of the neuro- 
museular junction in the chick embryo. J. Cell Biol.  82:195-21 t. 
33.  JesseL T. M., R. E. Siegel, and G. D. Fischbach.  1979. Induction ofacetylcholine receptors 
on cultured skeletal muscle by a  factor extracted from brain and spinal cord. Proc.  NatL 
Acad  Sci.  U. S. "4.76:5397  5401 
34.  Kawabuchi+  M,  M. Osame,  S. Watanabe.  A.  Igata, and  T,  Kanaseki.  1976.  Myopathic 
changes at the end-plate  region induced  by neostigmine  methylsulfate+ Ewerientia  (Ba- 
ce/I.  32:623-625. 
35.  Kidokoro. Y., and  E. Yeh.  1981.  Synaptic contacts between embryonic  Xenopus neurons 
and myotubes  formed from a rat skeletal muscle cell line. Dev  Biot  86:12  18. 
36.  Koenig J, and M. Vigny. 1978. Neural induction of the 16S acetylcholinesterase in muscle 
cell cultures. Nature (Lond).  271:75 77. 
37.  Lakowski, M. B,. W. H. Olson. and W.  D. Dettbarn.  1977.  Initial uhrastructural  abnor- 
malities at the motor endplate produced by a chotinesterase inhibitor. Exp. NeuroL  57:13 
33, 
38.  Leonard, J. P.. and M. M. Salpeter. 1979. Agonist-induced myopathy at the neuromuscular 
junction is mediated by calcium..L Cell BioL  82:811  819. 
39.  Lomo, T., and C. R. Slatet. 1980. Control of junctional acetylcholinesterase by neural and 
muscular influence in the rat..L P1~vsiol. (Lond,). 303:191  202. 
40.  Lowry, O. H. N. J. Rosenbrough, A, L. Farr, and R. J. Randall. I95 I. Protein measurement 
with the folin phenol reagent. J. Biol.  Chem.  193:265 275. 
41.  Marshall, L. M.. J. R. Sanes+ and U. J. McMahan.  1977. Reinnervation of original synaptic 
sites on muscle fiber basement membrane after disruption of the muscle cells. Proc  NatL 
Aead  Sci.  U, S. A. 74:3073-3077. 
42.  Miledi. R.  1960. Junctional and extrajunctional  actylcholine receptors in skeletal muscle 
fibers. Z  Pl~vsioL (Lond.).  151:24-30. 
43,  Moody-Corbett.  F,+ and M. W. Cohen.  1981. Localization ofcholinesterase at sites of high 
acetytcholine  receptor  density  on  embryonic  amphibian  muscle  ceils cultured  without 
nerves. J. NeuroscL  6;596-605. 
44.  Noble.  M.  D,.  J.  H.  Peacook,  and  W.  W.  Hofmann.  1979.  Prednisone-Neostigmine 
interactions at cholinergic junctions. Muscle Nerve.  2:155-157, 
45.  Obata. K.  1977.  Development of neuromuscular  transmission  in culture with a variety of 
neurons and in the presence of cholinergic substances and TTX. Brain  Res,  119:141  153. 
46.  Pittman, R.. and R. W. Oppenheim.  1979. Cell death of motoneurons  in the chick embryo 
spinal cord.  IV. Evidence that a  functional neuromuscular  interaction is involved in the 
regulation  of naturally  occurring cell death  and  the stabilization of synapses..L  Comp. 
Neurot.  187:425M.46. 
47.  Podleski. T. R.. D. Axelrod. P. Ravdin, 1. Greenberg. M. M. Johnson, and M. M. Salpeter 
1978.  Nerve  extract  induces  increase  and  redistribution  of acetylcholine  receptors  on 
clones muscle cells. Proc.  NatL  Acad  Sci  U. S. A. 75:2035  2039. 
48.  Reiness.  G.  C.,  and  Z.  W.  Hall.  1980.  The  developmental  change  in  immunological 
properties of the acetylcholine receptor in rat muscle. Dev.  BioL  81:324- 33 I+ 
49.  Roberts.  D, V., and S. Thesleff.  1969. Acetyleholine release from motor-nerve endings in 
rats treated with neostigmine. Eur.  ,L  Pharmacol  6:281-285. 
50.  Rubin,  L.  L., S.  M.  Schuetze,  C.  L. Weill, and  G.  D.  Fischbach.  1980.  Regulation  of 
acetylcholinesterase  appearance  at  neuromuscular  junctions  in  vitro.  Nature  (Lond). 
283:264 267. 
5 I.  Sakmann, B., and H. R. Brenner. 1978. Changes in synaptic channel during neuromuscular 
development.  Nature {Lond). 276:401~.02. 
52.  Salpeter, M  M.. H. Kasprzak,  H. Feng, and  H. Fertuck.  1979+ Endplates  after esterase 
inactivation in  vivo: correlation between esterase concentration,  functional response,  and 
fine structure, J. NeurocytoL  8:95-115. 
53.  Sanes. L  R., and Z. W, Hall.  1979.  Antibodies that bind specifically to synaptic sites on 
muscle fiber basal lamina..L Cell BioL  83:357 370. 
54.  Sanes, J.  R.  L. M.  Marshall, and  U. J.  MeMahan.  1978.  Reinnervation  of muscle fiber 
basal lamina after removal of myofibers, Differentiation of regenerating axons at original 
svnaptic sites.  J. ('ell BioL  78:176  +198. 
55,  SohaL G. S,  1981.  Neural influence on embryonic skeletal muscle. Anat.  Rec.  199:242A 
(Abstr.), 
56.  Sohal.  G.  S,  1981.  Uhrastructural  observations  on  the establishment  of neuromuscular 
junctions fofiowirtg prevention of embryonic death of motoneurons.  Exp. Neurol. 71:625 
634. 
57.  Sohal, G. S., T. L. Creazzo, and T. G. Oblak.  1979. Effects of chronic paralysis with ct- 
bungarotoxin on development of irmervatlon. Exp. NeuroL  66:619~328. 
58.  Sohal.  G.  S,,  and  R.  K.  Holt.  1978.  Identification  of the  trochlear  motoneurons  by 
retrograde transport of horseradish peroxidase. Exp. NeuroL  59:509 514. 
59.  Sohal, G. S, and R. K. Holt. 1980. Role of innervation on the embryonic development of 
skeletal muscle. Cell Tissue  Res. 210:383-393. 
60.  Srihari, T., and G.  Vrbova.  1978.  The  rote of muscle activity in the differentiation of 
neuromuscular junctions in the slow and fast chick muscles..L  NeurocytoL  7:529-540. 
61.  Steinbach. J. H., A. J.  Harris, J.  Patrick, D, Schuber.  and  S.  Heinemarm.  1973.  Nerve- 
muscle interaction in vitro. J. Gen.  Physiol.  62:255-270. 
62.  Stoney. S. D, and G. S. Sohal. 1978. Development of the trochlear nerve: neuromuscular 
transmission and electrophysiohigical properties. Exp. NeuroL  62:798-803. 
63.  Sytkowski, A. J., Z. Vogel, and  M,  W. Nirenberg.  1973. Development  of acetylcholine 
receptor clusters on cultured muscle ceils. Proc. NatL Acad Sci.  U. S. A, 70:270-274. 
64.  Tiodt,  T. N.,  E. X.  Albuquerque,  C.  S.  Hudson.  and  f.  E.  Rash.  1978+ N¢ostigmine- 
induced alterations at the mammalian neuromuscular junction.  I. Muscle contraction and 
electrophysiology. J. PharmacoL  Exp.  Ther.  205:326-339. 
65.  Toop. J.  1976. A  rapid method  for demonstrating  skeletal muscle motor innervation in 
frozen sections. Stain  Tech.  51:1~S. 
66.  Ward. M. D.  M.  S,  Forbes, and T. R. Johns.  1975.  Neostigmine  methylsulfate: does  it 
have a chronic effect as well as a transient one? ,4rch.  NeuroL  32:808-814. 
67.  Wemberg. C. B, and Z. W. Hall. 1979. Antibodies from patients with myasthenia gravis 
recognize  determinants  unique  to  extrajunctional  acetytcholine  receptors,  Proe,  NatL 
Acad.  ScL  U. S. A. 76:504-508. 
68.  Weldon,  P.  R,,  F.  Moody-Corbett,  and  M.  W.  Cohen.  1981.  Ultrastructure  of sites of 
cholinestrase activity on amphibian embryonic muscle ceils cultured without nerve. Dev. 
BioL  84:341-350. 
548  ThE  ~OURNAL  OF  CELL  BIOLOGY  •  VOLUME  94, 1982 